Monoclonal antibodies and checkpoint inhibitors for multiple myeloma
The importance of anti-CD38 monoclonal antibodies for multiple myeloma
Frontline treatment of elderly multiple myeloma patients and management of relapse/refractory
Enrique Ocio et al.
The ideal sequence: treating patients with CLL
The issue of relapse in Philadelphia chromosome-positive ALL patients and how to combat this